SHR-1210 plus apatinib as promising first-line treatment for advanced lung squamous carcinoma Dec. 3, 2019
Seattle Genetics, Astellas, Merck & Co. collaborate to study enfortumab + Keytruda in bladder cancer Dec. 3, 2019
Neurocrine Biosciences and Xenon collaborate to develop first-in-class treatments for epilepsy Dec. 3, 2019
RSS